Antiangiogenic therapy for primary and metastatic brain tumors. Review uri icon

Overview

abstract

  • We first provide the theoretic foundation of antiangiogenic therapy by describing the biology of angiogenesis as it applies to brain tumors. We then outline experimental antiangiogenic therapies that are being applied preclinically to brain tumors, as well as published clinical trial data and ongoing clinical trials in patients. Primary and metastatic brain tumors are covered, although there is far less exploration in the literature of brain metastases.

publication date

  • October 1, 2004

Research

keywords

  • Angiogenesis Inhibitors
  • Brain Neoplasms

Identity

Scopus Document Identifier

  • 5044225774

PubMed ID

  • 15474340

Additional Document Info

volume

  • 18

issue

  • 5